Table 2.
Fecal short-chain fatty acid concentrations (mmol/100 g dry weight) in the dietary (VLCD; n = 15) and sleeve gastrectomy (LSG, n = 15) intervention groups before intervention (month 0) and after 3 and 6 months.
| VLCD | LSG | |||||||
|---|---|---|---|---|---|---|---|---|
| Month 0 | Month 3 | Month 6 | P trend | Month 0 | Month 3 | Month 6 | P trend | |
| Acetate | 20.3 ± 3.8 | 15.6 ± 2.5 | 29.6 ± 1.9 | 0.4041 | 10.3 ± 1.7 | 16.5 ± 4.3 | 14.2 ± 3.0 | 0.3909 |
| Propionate | 5.8 ± 1.2 | 3.5 ± 0.5 | 3.7 ± 0.5 | 0.0954 | 3.5 ± 0.7 | 3.7 ± 0.8 | 3.5 ± 0.7 | 0.9743 |
| n-Butyrate | 4.5 ± 1.0 | 2.5 ± 0.6 | 2.5 ± 0.5 | 0.1095 | 2.2 ± 0.4 | 2.2 ± 0.6 | 2.5 ± 1.5 | 0.9232 |
| i-Butyrate | 0.6 ± 0.1 | 0.5 ± 0.1 | 0.5 ± 0.1 | 0.3393 | 0.4 ± 0.1 | 0.4 ± 0.1 | 1.0 ± 0.4 | 0.1973 |
| i-Valeriate | 0.8 ± 0.1 | 0.7 ± 0.1 | 0.7 ± 0.1 | 0.8427 | 0.6 ± 0.1 | 0.6 ± 0.1 | 0.6 ± 0.1 | 0.8458 |
| Caproate | 0.2 ± 0.0 | 0.2 ± 0.0 | 0.2 ± 0.0 | 0.6400 | 0.2 ± 0.0 | 0.2 ± 0.0 | 0.2 ± 0.0 | 0.8547 |
| Total SCFA | 30.7 ± 5.9 | 22.4 ± 3.8 | 21.9 ± 2.7 | 0.2862 | 18.2 ± 2.6 | 23.7 ± 6.3 | 24.9 ± 5.3 | 0.6192 |
SCFA: short chain fatty acids.